Status:
COMPLETED
Veno-venous Extracorporeal CO2 Removal in ARDS-patients to Treat Respiratory Acidosis
Lead Sponsor:
University Hospital, Ghent
Conditions:
ACUTE RESPIRATORY DISTRESS SYNDROME
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hypothesis: Extracorporeal removal of CO2 can treat hypercapnia and respiratory acidosis, which allows application of lung protective ventilation. This downgrading of mechanical ventilation promotes ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Acute onset of ARDS criteria on chest X-ray or CT scan
- Moderate (PaO2/ FiO2 \<200) or severe ARDS (PaO2/ FiO2 \<100) (FiO2: fraction of inspired oxygen)
- Respiratory acidosis with pH\< 7,25,
- With plateau pressure of 28cmH20 or higher,
- Exclusion criteria:
- \<18 years of age
- Pregnancy
- Obesity with BMI\> 30
- Contraindication for anticlotting therapy
- Chest wall abnormalities
- No presumed consent of representatives
Exclusion
Key Trial Info
Start Date :
February 20 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 12 2014
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01911533
Start Date
February 20 2014
End Date
September 12 2014
Last Update
December 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University Hospital
Ghent, Belgium, 9000